SINGLE-DOSE QUINIDINE TREATMENT INHIBITS MEXILETINE OXIDATION IN EXTENSIVE METABOLIZERS OF DEBRISOQUINE

被引：12

作者：

BROLY, F ^{[1
]}

VANDAMME, N ^{[1
]}

CARON, J ^{[1
]}

LIBERSA, C ^{[1
]}

LHERMITTE, M ^{[1
]}

机构：

[1] HOP CALMETTE,DEPT BIOCHIM,TOXICOL LAB,F-59045 LILLE,FRANCE

来源：

LIFE SCIENCES | 1991年 / 48卷 / 26期

关键词：

D O I：

10.1016/0024-3205(91)90618-L

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Urinary elimination of unchanged mexiletine, p-hydroxymexiletine (PHM), hydroxymethylmexiletine (HMM) and mexiletine N-glucuronide conjugate (MGC) was investigated before and after treatment with quinidine. All subjects were phenotyped as extensive metabolizers for debrisoquine oxidation. The total recovery of mexiletine and metabolites was significantly reduced after quinidine pretreatment. It is concluded that pretreatment with a very low dose of quinidine inhibits markedly the elimination of both major mexiletine metabolites (PHM and HMM) and likely decreases the overall elimination of mexiletine. That should lead to changes in mexiletine disposition and have clinical consequences during combination therapy with both drugs.

引用

页码：PL123 / PL128

页数：6

共 20 条

[11] HUMAN-LIVER CYTOCHROMES-P-450 INVOLVED IN POLYMORPHISMS OF DRUG OXIDATION [J].

GUENGERICH, FP ;

DISTLERATH, LM ;

REILLY, PEB ;

WOLFF, T ;

SHIMADA, T ;

UMBENHAUER, DR ;

MARTIN, MV .

XENOBIOTICA, 1986, 16 (05) :367-378

[12] QUINIDINE - POTENT INHIBITION OF SPARTEINE AND DEBRISOQUINE OXIDATION INVIVO [J].

INABA, T ;

TYNDALE, RE ;

MAHON, WA .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (02) :199-200

[13]

KAYE CM, 1977, POSTGRAD MED J, V53, P56

[14]

KUPFER A, 1985, DRUG METABOLISM MOL, P25

[15] DETERMINATION OF DEBRISOQUINE AND ITS 4-HYDROXY METABOLITE IN BIOLOGICAL-FLUIDS BY GAS-CHROMATOGRAPHY WITH FLAME-IONIZATION AND NITROGEN-SELECTIVE DETECTION [J].

LENNARD, MS ;

SILAS, JH ;

SMITH, AJ ;

TUCKER, GT .

JOURNAL OF CHROMATOGRAPHY, 1977, 133 (01) :161-166

[16]

MEYER UA, 1988, MICROSOMES DRUG OXID, P209

[17] COMPETITIVE-INHIBITION OF SPARTEINE OXIDATION IN HUMAN-LIVER BY BETA-ADRENOCEPTOR ANTAGONISTS AND OTHER CARDIOVASCULAR DRUGS [J].

OTTON, SV ;

INABA, T ;

KALOW, W .

LIFE SCIENCES, 1984, 34 (01) :73-80

[18] RELATIONSHIP BETWEEN PLASMA MEXILETINE LEVELS AT STEADY-STATE - PRESENCE OF VENTRICULAR ARRHYTHMIAS AND SIDE-EFFECTS [J].

PEYRIEUX, JC ;

BOISSEL, JP ;

LEIZOROVICZ, A .

FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1987, 1 (01) :45-57

[19] QUINIDINE AND THE IDENTIFICATION OF DRUGS WHOSE ELIMINATION IS IMPAIRED IN SUBJECTS CLASSIFIED AS POOR METABOLIZERS OF DEBRISOQUINE [J].

SPEIRS, CJ ;

MURRAY, S ;

BOOBIS, AR ;

SEDDON, CE ;

DAVIES, DS .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (06) :739-743

[20]

WOOSLEY RL, 1984, AM HEART J, V107, P1086

← 1 2 →